Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.65
-$0.01-0.98%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/7/2026
-
Globe Newswire
5/1/2026
-
Newsfile Corp. - News Releases
4/30/2026
-
Newsfile Corp. - News Releases
3/27/2026
-
Newsfile Corp. - News Releases
3/26/2026
-
Newsfile Corp. - News Releases
3/12/2026
-
Globe Newswire
3/11/2026
-
TipRanks Financial Blog
3/6/2026
-
Newsfile Corp. - News Releases
1/31/2026
-
Ticker Report
1/13/2026
-
Newsfile Corp. - News Releases
12/31/2025
-
Ticker Report
12/29/2025
-
TipRanks Financial Blog
12/18/2025
-
TipRanks Financial Blog
11/29/2025
-
Nasdaq News: Markets
11/28/2025
-
TipRanks Financial Blog
11/26/2025
-
TipRanks Financial Blog
11/21/2025
-
TipRanks Financial Blog
11/21/2025
-
Newsfile Corp. - News Releases
11/17/2025
-
TipRanks Financial Blog
11/3/2025
-
Newsfile Corp. - News Releases
10/22/2025
-
GuruFocus
10/22/2025
-
ACCESS Newswire
10/22/2025
-
ACCESS Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 31, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
240 403 4212
Address
401 Professional Drive
Gaithersburg, MD 20879
Gaithersburg, MD 20879
Country
Year Founded
Business Description
Sector
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven...
more